AKRO - Akero Therapeutics - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

AKRO is currently covered by 2 analysts with an average price target of $54. This is a potential upside of $23.21 (-1.19%) from yesterday's end of day stock price of $54.65.

Akero Therapeutics's activity chart (see below) currently has 92 price targets and 79 ratings on display. The stock rating distribution of AKRO is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 39.54% with an average time for these price targets to be met of 204.46 days.

Highest price target for AKRO is $54, Lowest price target is $54, average price target is $54.

Most recent stock forecast was given by PRAKHAR AGRAWAL from CANTOR FITZGERALD on 10-Dec-2025. First documented stock forecast 15-Jul-2019.

Best performing analysts who are covering AKRO - Akero Therapeutics:

Edward Nash Ed Arce Liisa Bayko Joshua Schimmer Eliana Merle

Currently out of the existing stock ratings of AKRO, 2 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 19-Sep-2023

9 months 12 days ago
(10-Dec-2025)

0/4 (0%)

$29.93 (96.33%)

Buy Since 04-Sep-2025

$54

$-0.65 (-1.19%)

$72

11 months 12 days ago
(10-Oct-2025)

2/7 (28.57%)

$0.12 (0.22%)

70

Buy Since 10-Feb-2020

$54

$-0.65 (-1.19%)

$56

11 months 13 days ago
(09-Oct-2025)

7/10 (70%)

$-0.08 (-0.15%)

356

Buy Since 19-Dec-2022

$84

$29.35 (53.71%)

$84

1 years 1 months 16 days ago
(06-Aug-2025)

1/7 (14.29%)

$31.21 (59.12%)

329

Buy Since 04-Aug-2025

$76

$21.35 (39.07%)

1 years 1 months 18 days ago
(04-Aug-2025)

0/1 (0%)

$27.38 (56.31%)

Show more analysts

Please expand the browser size to see the chart

What is AKRO (Akero Therapeutics) average time for price targets to be met?

On average it took 204 days for the stock forecasts to be reached, with an average price target met ratio of 39.54%.

Which analyst most recently updated their price target on AKRO (Akero Therapeutics)?

Prakhar Agrawal

Which analyst has the most public recommendations on AKRO (Akero Therapeutics)?

Prakhar Agrawal works at CANTOR FITZGERALD and has 2 price targets and 2 ratings on AKRO

Which analyst is the currently most bullish on AKRO (Akero Therapeutics)?

Eliana Merle with the highest potential upside of $54.35

Which analyst is the currently most reserved on AKRO (Akero Therapeutics)?

Liisa Bayko with the lowest potential downside of -$16.65

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?